Literature DB >> 7294376

Succinylcholine neuromuscular blockade in subjects homozygous for atypical plasma cholinesterase.

J Viby-Mogensen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7294376     DOI: 10.1097/00000542-198110000-00015

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  8 in total

Review 1.  Neuromuscular blocking drugs.

Authors:  D R Bevan
Journal:  Can Anaesth Soc J       Date:  1983-05

2.  Multiple neuromuscular blocking agents and reversal in a patient with absent plasma cholinesterase.

Authors:  M H Dykes; S C Cheng; H Cohen; R F Valle
Journal:  Can Anaesth Soc J       Date:  1986-09

Review 3.  Adverse effects of depolarising neuromuscular blocking agents. Incidence, prevention and management.

Authors:  W J Book; M Abel; J B Eisenkraft
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

4.  Succinylcholine relaxant: Anaesthesiologist not relaxed!

Authors:  Sarah Ninan; L Jeslin; Pa Saravanan; Kamal Kumar
Journal:  Indian J Anaesth       Date:  2010-01

5.  Frequency and enzyme activity of the butyrylcholinesterase K-variant in a Turkish population.

Authors:  Melih O Babaoglu; Turgay Ocal; Banu Bayar; S Oguz Kayaalp; Atila Bozkurt
Journal:  Eur J Clin Pharmacol       Date:  2004-01-21       Impact factor: 2.953

6.  Succinylcholine apnoea: attempted reversal with anticholinesterases.

Authors:  D R Bevan; F Donati
Journal:  Can Anaesth Soc J       Date:  1983-09

7.  Comparison of atracurium and succinylcholine for electroconvulsive therapy in a patient with atypical plasma cholinesterase.

Authors:  D R Hickey; J P O'Connor; F Donati
Journal:  Can J Anaesth       Date:  1987-05       Impact factor: 5.063

8.  Selective reversal of muscle relaxation in general anesthesia: focus on sugammadex.

Authors:  Sorin J Brull; Mohamed Naguib
Journal:  Drug Des Devel Ther       Date:  2009-09-21       Impact factor: 4.162

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.